The SAIC's new guidelines make it mandatory for dominant market players to license their IP rights. Companies – high tech and pharmaceutical in particular – will need to be careful to avoid AML investigations
The SAIC's new guidelines make it mandatory for dominant market players to license their IP rights. Companies – high tech and pharmaceutical in particular – will need to be careful to avoid AML investigations